Lv619
1704 积分 2024-09-28 加入
Predicting therapeutic response to neoadjuvant immunotherapy based on an integration model in resectable stage IIIA (N2) non–small cell lung cancer
3天前
已完结
Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis
1个月前
已完结
Structure–function–rescue: the diverse nature of common p53 cancer mutants
2个月前
已完结
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others
2个月前
已完结
TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
2个月前
已完结
IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell lines
2个月前
已完结
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
2个月前
已完结
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
2个月前
已完结
P1.07.43 Clinico-Genomic Correlates of Pathologic Response to Neoadjuvant Chemo-Immunotherapy in Patients With Early-Stage NSCLC
5个月前
已关闭
Genomic scoring to determine clinical benefit of immunotherapy by targeted sequencing
5个月前
已完结
皖公网安备34019202002308
